Bee Venom Phonophoresis on Mild to Moderate Localized Plaque Psoriasis on Knee Joint (NCT06106230) | Clinical Trial Compass
CompletedNot Applicable
Bee Venom Phonophoresis on Mild to Moderate Localized Plaque Psoriasis on Knee Joint
Egypt100 participantsStarted 2024-01-01
Plain-language summary
Chronic plaque psoriasis, or psoriasis vulgaris, is a chronic inflammatory skin disease characterized by well demarcated, erythematous, scaly plaques on the extensor surfaces of the body and scalp. The lesions may occasionally itch or sting, and may bleed when injured. Dystrophic nail changes or nail pitting are found in more than one third of people with chronic plaque psoriasis, and psoriatic arthropathy occurs in 1% to more than 10%. The condition waxes and wanes, with wide variations in course and severity among individuals.
Who can participate
Age range
20 Years – 50 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
* Symmetrical mild-to-moderate chronic plaque psoriasis
* Chronic stable plaque psoriasis
* Bilateral lesions of approximately 25 cm²
* Had not been receiving any treatment for at least one month.
* Those with infection or malignancy and/or subjects who had undergone major surgery in the past 6 months were not included in the study.
* Patients that had not undergone systemic treatment for psoriasis during the previous 3 months were included in the study
* age 20 - 50 with mild to moderate knee plaque psoriasis
* Symmetrical plaque psoriasis
* PASI score affected \< 20
* BSA of knee involvement : 2% to 20%
Exclusion criteria
* Patients with malignant tumors, those diagnosed with psoriatic arthritis or any other systemic inflammatory disease, or those using medication were excluded from the study.
* Pregnancy
* Receiving steroid preparations
* topical or UVB therapy within previous 4 wks
* Systemic corticosteroids, PUVA, or laser phototherapy within previous 4 wks
* Other systemic therapies or biologicals within previous 3 wks
* Widespread psoriasis
* Hypercalcaemia
* Liver or renal disease
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Neutrophils / Lymphocyte Ratio (Neutrophil-to-Lymphocyte Ratio)